Utah Medical Products, Inc. Stock

Equities

UTMD

US9174881089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2024-04-26 EDT 5-day change 1st Jan Change
65.92 USD -0.56% Intraday chart for Utah Medical Products, Inc. -3.88% -21.73%
Sales 2022 52.28M 71.46M Sales 2023 50.22M 68.65M Capitalization 306M 418M
Net income 2022 16M 21.87M Net income 2023 16M 21.87M EV / Sales 2022 5.55 x
Net cash position 2022 74.66M 102M Net cash position 2023 92.53M 126M EV / Sales 2023 4.24 x
P/E ratio 2022
22.2 x
P/E ratio 2023
18.4 x
Employees 180
Yield 2022
1.16%
Yield 2023
1.41%
Free-Float 93.48%
More Fundamentals * Assessed data
Dynamic Chart
Utah Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Reports Q1 Revenue $11.3M MT
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q1 EPS $1.09 MT
Utah Medical Products Keeps Quarterly Dividend at $0.30 Per Share, Payable on April 3 to Shareholders on March 15 MT
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992. CI
Utah Medical Products, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Utah Medical Products, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
North American Morning Briefing : Microsoft Kicks -2- DJ
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992. CI
Utah Medical Products Lifts Quarterly Dividend by 1.7% to $0.30 a Share, Payable Jan. 3 to Shareholders of Record as of Dec. 15 MT
Utah Medical Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
North American Morning Briefing : Yields Fall -2- DJ
Utah Medical Products Maintains Quarterly Dividend at $0.295/Share, Payable Oct. 3 to Shareholders of Record Sept. 15 MT
Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023 CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q2 Revenue $12.9M MT
More news
1 day-0.56%
1 week-3.88%
Current month-7.30%
1 month-3.26%
3 months-21.40%
6 months-15.24%
Current year-21.73%
More quotes
1 week
65.91
Extreme 65.91
69.27
1 month
65.91
Extreme 65.91
71.55
Current year
65.91
Extreme 65.91
85.76
1 year
65.91
Extreme 65.91
100.59
3 years
65.91
Extreme 65.91
133.87
5 years
65.91
Extreme 65.91
133.87
10 years
44.52
Extreme 44.52
133.87
More quotes
Managers TitleAgeSince
Chief Executive Officer 77 92-11-30
Director of Finance/CFO 54 05-12-31
Director/Board Member 64 89-12-31
Members of the board TitleAgeSince
Chief Executive Officer 77 92-11-30
Director/Board Member 86 95-12-31
Director/Board Member 64 89-12-31
More insiders
Date Price Change Volume
24-04-26 65.92 -0.56% 22,564
24-04-25 66.29 -1.30% 24,010
24-04-24 67.16 -0.59% 25,241
24-04-23 67.56 -0.84% 16,812
24-04-22 68.13 -0.66% 12,747

Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm

More quotes
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
Related indices
More about the company